These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10226744)

  • 1. Spinal muscular atrophy: molecular pathophysiology.
    Gendron NH; MacKenzie AE
    Curr Opin Neurol; 1999 Apr; 12(2):137-42. PubMed ID: 10226744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal muscular atrophy: untangling the knot?
    Biros I; Forrest S
    J Med Genet; 1999 Jan; 36(1):1-8. PubMed ID: 9950358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis.
    Parboosingh JS; Meininger V; McKenna-Yasek D; Brown RH; Rouleau GA
    Arch Neurol; 1999 Jun; 56(6):710-2. PubMed ID: 10369311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal muscular atrophy: a disease of altered RNA metabolism?
    Wellington C
    Clin Genet; 1998 Jul; 54(1):23-5. PubMed ID: 9727735
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
    Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
    Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence of a 131-kb region of 5q13.1 containing the spinal muscular atrophy candidate genes SMN and NAIP.
    Chen Q; Baird SD; Mahadevan M; Besner-Johnston A; Farahani R; Xuan J; Kang X; Lefebvre C; Ikeda JE; Korneluk RG; MacKenzie AE
    Genomics; 1998 Feb; 48(1):121-7. PubMed ID: 9503025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins.
    Liu Q; Fischer U; Wang F; Dreyfuss G
    Cell; 1997 Sep; 90(6):1013-21. PubMed ID: 9323129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutics development for spinal muscular atrophy.
    Sumner CJ
    NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).
    Wirth B
    Hum Mutat; 2000; 15(3):228-37. PubMed ID: 10679938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the role of SMN1 and SMN2 haploinsufficiency as a risk factor for Hirayama's disease: clinical, neurophysiological and genetic characteristics in a Spanish series of 13 patients.
    Gamez J; Also E; Alias L; Corbera-Bellalta M; Barceló MJ; Centeno M; Raguer N; Gratacós M; Baiget M; Tizzano EF
    Clin Neurol Neurosurg; 2007 Dec; 109(10):844-8. PubMed ID: 17850955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular basis of spinal muscular atrophy: th SMN gene].
    Tizzano E; Baiget M
    Neurologia; 2000 Nov; 15(9):393-400. PubMed ID: 11195146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal muscular atrophy: molecular genetics and diagnostics.
    Ogino S; Wilson RB
    Expert Rev Mol Diagn; 2004 Jan; 4(1):15-29. PubMed ID: 14711346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy.
    He J; Zhang QJ; Lin QF; Chen YF; Lin XZ; Lin MT; Murong SX; Wang N; Chen WJ
    Gene; 2013 Apr; 518(2):325-9. PubMed ID: 23352792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the neuronal apoptosis inhibitory protein gene in families with spinal muscular atrophy.
    Salahshourifar I; Shafeghati Y; Golkar Z; Najmabadi H
    Arch Iran Med; 2007 Oct; 10(4):509-13. PubMed ID: 17903057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy.
    Al-Jumah M; Majumdar R; Al-Rajeh S; Awada A; Chaves-Carbello E; Salih M; Al-Shahwan S; Al-Subiey K; Al-Uthaim S
    Saudi Med J; 2003 Oct; 24(10):1052-4. PubMed ID: 14578966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy.
    Watihayati MS; Fatemeh H; Marini M; Atif AB; Zahiruddin WM; Sasongko TH; Tang TH; Zabidi-Hussin ZA; Nishio H; Zilfalil BA
    Brain Dev; 2009 Jan; 31(1):42-5. PubMed ID: 18842367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing therapies for spinal muscular atrophy.
    Wertz MH; Sahin M
    Ann N Y Acad Sci; 2016 Feb; 1366(1):5-19. PubMed ID: 26173388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomeric Region of the Spinal Muscular Atrophy Locus Is Susceptible to Structural Variations.
    Noguchi Y; Onishi A; Nakamachi Y; Hayashi N; Harahap NI; Rochmah MA; Shima A; Yanagisawa S; Morisada N; Nakagawa T; Iijima K; Kasagi S; Saegusa J; Kawano S; Shinohara M; Tairaku S; Saito T; Kubo Y; Saito K; Nishio H
    Pediatr Neurol; 2016 May; 58():83-9. PubMed ID: 27268759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hnRNP M facilitates exon 7 inclusion of SMN2 pre-mRNA in spinal muscular atrophy by targeting an enhancer on exon 7.
    Cho S; Moon H; Loh TJ; Oh HK; Cho S; Choy HE; Song WK; Chun JS; Zheng X; Shen H
    Biochim Biophys Acta; 2014; 1839(4):306-15. PubMed ID: 24533984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gene copy ratios of SMN1/SMN2 in Japanese carriers with type I spinal muscular atrophy.
    Diep Tran T; Kroepfl T; Saito M; Nagura M; Ichiseki H; Kubota M; Toda T; Sakakihara Y
    Brain Dev; 2001 Aug; 23(5):321-6. PubMed ID: 11504604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.